Research Article
Cranberry for Bacteriuria in Individuals with Spinal Cord Injury: A Systematic Review and Meta-Analysis
Table 4
Specific risk of bias assessment.
| | Study name | Reid | Linsenmeyer | Waites | Lee | Hess | Sappal | | Year | 2001 | 2004 | 2004 | 2007 | 2008 | 2018 |
| | Groups balanced for lesion level/urine collection | Yes 0.1 | Yes 0.1 | Unbalanced catheterization (treatment/control 65.4/36.3%) | No data for each of the 4 arms | Yes 0.1 | Not reported | | UTI diagnosis including autonomic dysreflexia | No | Yes 0.1 | No | Yes 0.1 | Yes 0.1 | No | | Comorbidity and drug use specified | No | No | No | No | No | No | | Proper control | Yes 0.3 | Yes 0.3 | Yes 0.3 | Placebo+MH | Yes 0.3 | Yes 0.3 | | Compliance assessment | No | No | Pills’ count 0.1 | No | Pills’ count 0.1 | No | | Dietary record | No | No | Only fluid intake 0.03 | No | No | No | | Food antioxidant intake | Only no CB/vit. C 0.025 | Only no CB 0.025 | Only no CB 0.025 | No | No | Only no CB 0.025 | | Washout and/or run-in | 2d-w/o only | Yes 0.05 | No | No | No | No | | Marker of bioavailability | No | No | No | No | No | No | | Double blinding | No | Yes 0.05 | Yes 0.05 | Yes 0.05 | Yes 0.05 | Yes 0.05 | | No funding support | Yes 0.03 (no conflict) | Yes 0.03 | Yes 0.03 | Brucia Pharmaceuticals | Yes 0.03 | Yes (critical versus sponsor) 0.03 | | No supplement donation | Yes 0.01 | Kessler Pharmacy | AIM This Way | Yes 0.01 | Cran-Max Swiss | Yes 0.01 | | Quality score (range 0–1) | 0.465 | 0.655 | 0.535 | 0.16 | 0.68 | 0.415 |
|
|
CB: cranberry; MH: methenamine hippurate; UTI: urinary tract infection.
|
